Evidence map›Paper›PMID 31537850›Full record

ArticleScientific reports2019

Disease control efficacy of 32,33-didehydroroflamycoin produced by Streptomyces rectiviolaceus strain DY46 against gray mold of tomato fruit.

Jeong Do Kim, Min Young Park, Byeong Jun Jeon, Beom Seok Kim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Evaluation ofFrontiers in microbiology · 2024
    Article
  4. Article
  5. A Coating Based on Bioactive Compounds fromPlants (Basel, Switzerland) · 2023
    Article
  6. Frontiers in plant science · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jeong Do KimKorea Institute of Science and Technology (KIST) Gangneung Institute, Gangneung, 25451, Republic of Korea.ORCID http://orcid.org/0000-0001-6388-522X
Min Young ParkDepartment of Biosystems and Biotechnology, Korea University Graduate School, Seoul, 02841, Republic of Korea.
Byeong Jun JeonDepartment of Biosystems and Biotechnology, Korea University Graduate School, Seoul, 02841, Republic of Korea.
Beom Seok KimDepartment of Biosystems and Biotechnology, Korea University Graduate School, Seoul, 02841, Republic of Korea. biskim@korea.ac.kr.
Korea University · KRKorea Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the efficacy of synthetic fungicides in controlling postharvest diseases, public concerns regarding chemical residues in food and an increase in drug-resistant strains of pathogens have led to a need for new agents to control postharvest diseases. The current study was performed to find control agents of microbial origin that are effective on gray mold of tomato fruits. We recently isolated Streptomyces rectiviolaceus DY46, which has antagonistic activity against various plant pathogenic fungi. The incidence of gray mold of tomato fruits was markedly reduced by 80.0% in tomatoes treated with the cell extract of Streptomyces rectiviolaceus DY46 compared with the control tomatoes. The active ingredient was purified from the cell extract of DY46 and identified to be 32,33-didehydroroflamycoin (DDHR). DDHR displayed MICs (minimal inhibitory concentrations) against the mycelial growth of various plant pathogenic fungi at concentrations of 8-64 mg L

Indexed as

BotrytisFilipinFruitFungiFungicides, IndustrialPlant DiseasesSolanum lycopersicumSpores, FungalStreptomyces32,33-didehydroroflamycoinFilipinFungicides, Industrial

Identifiers

PMID31537850
PMCPMC6753085
OpenAlexW2973759634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.